Case File
efta-efta02011631DOJ Data Set 10CorrespondenceEFTA Document EFTA02011631
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta02011631
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
Jeffrey,
You sold the PFE note up 17.1% ($513,000)
Sold $5 MM / bought CNY 1 year forward (06/11/2012) @ 6.3636
Bought 2.5 MM of the ING FRN Preferreds (CUSIP 44978NAA3) @ 97. Purchased for June 15th, 2011
settlement (maturity of the 5 MM Ford bonds)
Let me know if you have any questions.
Thanks again.
David J. Giuffrida
J.P. Morgan I Global Investment Opportunities Group
40 West 57th Street, Floor 33
New York, NY 10019
IRS Circular 230 Disclosure:
JPMorgan Chase & Co. and its affiliates do not provide tax advice. Accordingly, any discussion of U.S. tax
matters contained herein (including any attachments) is not intended or written to be used, and cannot be used,
in connection with the promotion, marketing or recommendation by anyone unaffiliated with JPMorgan Chase &
Co. of any of the matters addressed herein or for the purpose of avoiding U.S. tax-related penalties.
EFTA_R1_00513350
EFTA02011631
This is not an official confirmation.
From: Barrett, Paul
Sent: Wednesday, June 08, 2011 12:16 PM
To: Jeffrey Epstein
Cc: Giuffrida, David J
Subject: Pfizer
Hi Jeffrey
EFTA_R1_00513351
EFTA02011632
Our Pfizer market plus has been a big beneficiary of the defensive sector rotation. We are up 17% on the
$3MM and we feel that it is a good time to take profits.
Also lyr CNY forward points have come into less than a 2% premium and I think we should add $SMM to
our $l0MM position.
Our $5mm of Ford bonds mature next week. As a replacement I would add $2.SMM ING Pfds at 97.00.
We think these could get called at 100 next year. The balance we should leave in cash for now.
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
40W 57th Street, 33rd Floor, New York, NY 10019
212-622-2770 (W)
212-310-0108 (F)
paul.s.barrettfripmorgan.com
EFTA_R1_00513352
EFTA02011633
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
paul.s.barrettfripmorgan.comPhone
212-310-0108Phone
212-622-2770Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.